Focus Partners Wealth purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 3,866 shares of the health services provider's stock, valued at approximately $289,000.
Other hedge funds also recently made changes to their positions in the company. Norges Bank acquired a new position in Maximus in the fourth quarter valued at $71,443,000. Federated Hermes Inc. raised its holdings in shares of Maximus by 74.8% in the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock worth $65,912,000 after purchasing an additional 377,705 shares during the period. AQR Capital Management LLC lifted its stake in shares of Maximus by 189.1% in the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock valued at $31,599,000 after purchasing an additional 276,859 shares in the last quarter. Marshall Wace LLP lifted its stake in shares of Maximus by 1,319.1% in the 4th quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock valued at $16,742,000 after purchasing an additional 208,463 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after purchasing an additional 205,564 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Down 1.7%
Shares of NYSE:MMS traded down $1.27 during midday trading on Wednesday, hitting $73.43. 31,056 shares of the company's stock traded hands, compared to its average volume of 559,735. The firm's fifty day moving average price is $69.59 and its two-hundred day moving average price is $71.93. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a market cap of $4.14 billion, a PE ratio of 15.80 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company posted $1.57 earnings per share. The firm's revenue was up 1.0% compared to the same quarter last year. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is 23.86%.
Insider Activity
In other news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.60% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
Check Out Our Latest Research Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.